Compare · BBH vs CBOE
BBH vs CBOE
Side-by-side comparison of VanEck Vectors Biotech ETF (BBH) and Cboe Global Markets, Inc. (CBOE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBH and CBOE operate in n/a (n/a), so they compete in similar markets.
- CBOE carries a market cap of $13.01B.
- CBOE has hit the wire 8 times in the past 4 weeks while BBH has been quiet.
- CBOE has more recent analyst coverage (25 ratings vs 0 for BBH).
Cboe Global Markets, Inc.
Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, European Equities, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities; and offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The European Equities segment offers pan-European listed equities transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
Latest BBH
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
- Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
- New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
- Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
- FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
- VanEck Launches Robotics ETF (IBOT)
- US Judge Weighs Nationwide Ban On Abortion Pills
Latest CBOE
- SEC Form 4 filed by EVP, Equities and Spot Markets Fischer Heidi
- SEC Form 4 filed by EVP, CHIEF RISK OFFICER Duinstra Boudewijn
- Director Froetscher Janet P sold $261,376 worth of shares (937 units at $278.95) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 12,870 units (SEC Form 4)
- SEC Form 3 filed by new insider Duinstra Boudewijn
- Cboe Global Markets Declares Increased Third-Quarter 2026 Dividend
- Cboe Clear Europe to Expand Securities Financing Transactions Clearing into Fixed Income
- Cboe Global Markets Reports Trading Volume for July 2026
- Cboe Completes Sale of Cboe Australia to TMX Group
- SEC Form 10-Q filed by Cboe Global Markets, Inc.
- Cboe Global Markets Reports Results for Second Quarter 2026